Human CCL17/TARC Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 8 publications

Product Code	Brand	Quantity
18777148	R&D Systems MAB364-SP	25 μg
18778729	R&D Systems MAB364-100	100 μg
18121381	R&D Systems MAB364-500	500 μg

Description

CCL17/TARC Monoclonal specifically detects CCL17/TARC in Human samples. It is validated for Neutralization, ELISA Capture (Matched Antibody Pair).

Specifications

• Antigen: CCL17/TARC
• Dilution: Neutralization 0.4-2.0 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL
• Classification: Monoclonal
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: Q92583.1
• Gene ID (Entrez): 6361
• Immunogen: E. coli-derived recombinant human CCL17/TARC Ala24-Ser94 Accession # Q92583.1
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects human CCL17/TARC in ELISAs. Does not cross-react with recombinant human (rh) CCL2, 3, 4, 5, 7, 8, 11, 13, 16, 18, 19, 20, 21, 22, 23, 24, 25, rmCCL2, 3, 4, 5, 7, 9/10/MIP-1 gamma , 11, 12, 21, 22, 25, or rrCCL20.

• Clone: 54026
• Applications: Neutralization, ELISA
• Conjugate: Unconjugated
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: ABCD-2, CC chemokine TARC, C-C motif chemokine 17, chemokine (C-C motif) ligand 17, MGC138273, SCYA17, SCYA17MGC138271, small inducible cytokine subfamily A (Cys-Cys), member 17, Small-inducible cytokine A17, T cell-directed CC chemokine, TARC, TARCA-152E5.3, Thymus and activation-regulated chemokine
• Gene Symbols: CCL17
• Isotype: IgG1
• Purification Method: Protein A or G purified from ascites
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.